Deep Track Capital, Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$6.12B
Q ending 2026-03-31
Prior quarter
$5.61B
Q ending 2025-12-31
Change
+9.2% QoQ · +98.3% YoY
Positions
63
reported holdings
Largest positions
All 63 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Spdr Series Trust | XBI | Put | $1.28B | 10.0M |
| Guardant Health Inc | GH | Shares | $308.4M | 3.3M |
| Immunovant Inc | IMVT | Shares | $286.3M | 11.5M |
| Tarsus Pharmaceuticals Inc | TARS | Shares | $252.5M | 3.6M |
| Vaxcyte Inc | PCVX | Shares | $249.9M | 4.3M |
| Structure Therapeutics Inc | GPCR | Shares | $206.3M | 4.3M |
| Axsome Therapeutics Inc. | AXSM | Shares | $185.9M | 1.1M |
| Apellis Pharmaceuticals Inc | APLS | Shares | $182.3M | 4.5M |
| Ocular Therapeutix Inc | OCUL | Shares | $166.7M | 19.7M |
| Vera Therapeutics Inc | VERA | Shares | $165.2M | 4.1M |
| Alumis Inc | ALMS | Shares | $149.2M | 6.8M |
| Ionis Pharmaceuticals Inc | IONS | Shares | $146.4M | 1.9M |
| Nuvalent Inc | 5AX | Shares | $141.0M | 1.4M |
| Alkermes Plc | Shares | $127.0M | 3.6M | |
| Centessa Pharmaceuticals Plc | 260 | Shares | $125.4M | 3.2M |
| Moonlake Immunotherapeutics | MLTX | Shares | $119.5M | 6.4M |
| Maze Therapeutics Inc | MAZE | Shares | $103.8M | 3.5M |
| Oruka Therapeutics Inc | ORKA | Shares | $99.8M | 2.0M |
| Nurix Therapeutics Inc | NRIX | Shares | $98.4M | 6.3M |
| Genmab A/S | GMAB | Shares | $98.3M | 3.7M |
| Cytokinetics Inc | CYTK | Shares | $90.6M | 1.4M |
| Grail Inc | GRAL | Shares | $89.0M | 1.7M |
| Lb Pharmaceuticals Inc | LBRX | Shares | $82.7M | 3.4M |
| Mbx Biosciences Inc | MBX | Shares | $82.3M | 2.8M |
| Bicara Therapeutics Inc | BCAX | Shares | $80.8M | 4.1M |
| Compass Pathways Plc | CMPS | Shares | $67.3M | 12.2M |
| Biomarin Pharmaceutical Inc | BMRN | Shares | $65.0M | 1.1M |
| Bridgebio Pharma Inc | BBIO | Shares | $62.5M | 841K |
| Immunocore Hldgs Plc | IMCR | Shares | $58.2M | 1.9M |
| Tango Therapeutics Inc | TNGX | Shares | $57.5M | 2.8M |
| Definium Therapeutics Inc | DFTX | Shares | $56.7M | 3.0M |
| Terns Pharmaceuticals Inc | 430 | Shares | $56.6M | 1.1M |
| Geron Corp | GERN | Shares | $47.3M | 31.7M |
| Ani Pharmaceuticals Inc | ANIP | Shares | $46.1M | 600K |
| Cormedix Inc | CRMD | Shares | $42.6M | 6.3M |
| Ataibeckley Inc | ATAI | Shares | $42.5M | 12.0M |
| Celldex Therapeutics Inc New | CLDX | Shares | $40.7M | 1.3M |
| Cogent Biosciences Inc | COGT | Shares | $38.5M | 1.0M |
| Corvus Pharmaceuticals Inc | CRVS | Shares | $36.5M | 2.5M |
| Dyne Therapeutics Inc | DYN | Shares | $36.3M | 2.0M |
| Soleno Therapeutics Inc | SLNOEUR | Shares | $36.1M | 1.1M |
| Aclaris Therapeutics Inc | ACRS | Shares | $35.0M | 9.3M |
| Veradermics Inc | MANE | Shares | $31.6M | 500K |
| Verastem Inc | VSTM | Shares | $30.4M | 5.7M |
| Engene Holdings Inc | Shares | $29.8M | 4.4M | |
| Viridian Therapeutics Inc | VRDN | Shares | $27.3M | 1.4M |
| X4 Pharmaceuticals Inc | XFOR | Shares | $26.2M | 6.3M |
| Solid Biosciences Inc | SLDB | Shares | $25.7M | 3.6M |
| Enanta Pharmaceuticals Inc | ENTA | Shares | $24.7M | 2.0M |
| Apogee Therapeutics Inc | APGE | Shares | $24.0M | 285K |
| Kura Oncology Inc | KURA | Shares | $21.5M | 2.6M |
| Century Therapeutics Inc | IPSC | Shares | $21.4M | 9.5M |
| Beam Therapeutics Inc | BEAM | Shares | $19.6M | 821K |
| Context Therapeutics Inc | CNTX | Shares | $19.4M | 7.4M |
| Personalis Inc | PSNL | Shares | $19.1M | 3.0M |
| Janux Therapeutics Inc | JANX | Shares | $16.5M | 1.2M |
| Promis Neurosciences Inc | PMN | Shares | $10.6M | 836K |
| Crescent Biopharma Inc. | Shares | $8.3M | 454K | |
| Inventiva Sa | IVA | Shares | $6.8M | 1.2M |
| Larimar Therapeutics Inc | LRMR | Shares | $6.8M | 1.5M |
| Cybin Inc | HELP | Shares | $6.3M | 1.3M |
| Billiontoone Inc | BLLN | Shares | $3.9M | 50K |
| Aligos Therapeutics Inc | ALGS | Shares | $3.3M | 444K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.